Chiasma, Inc., a U.S. privately–held biopharma company developing octreotide capsules for the orphan condition acromegaly, today announced two new studies presented at the 97th Endocrine Society (ENDO) Annual Meeting in San Diego, Calif. The studies provide additional data from Chiasma’s Phase III trial and new findings on the patient burden of current injection therapies.
“We now have data to help clinicians determine whether octreotide capsules, if approved, are likely to help their patient with acromegaly maintain response,” said Shlomo Melmed, M.D., senior vice president and dean, Cedars–Sinai Medical Center, Los Angeles and global study principal investigator. “Furthermore, the Phase III results show the safety and efficacy of octreotide capsules can be reliably determined within 12 weeks of initiating therapy.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7436451-endo-chiasma-clinical-data/
As sleaze oozes from the Pentagon,
banished Marine and Naval Academy alum Susanna Marcasi finds a web of
corruption and must take on a man to whom all are beholden, Defense
Secretary Manfred Stahl. Can she bring down the cloistered power
brokers deep within the military’s superstructure and survive? Blood
Stripe: The Susanna Marcasi Chronicles. Find out more at:
http://www.GinaMariaDiNicolo.com or on Amazon at:
http://j.mp/Blood-Stripe Cincinnati City Beat and
Amazon reviewer John Kelly says “Like a literary version of ‘A Few Good
Men (and Women)’ on steroids, Gina Maria DiNicolo rips into your
emotional core like a ‘kill shot’ from page one and never lets up for
322 pages. This book, not for the weak of heart, tells the story of
strength, courage and no mercy in the most elite units of the U.S.
Armed Forces.” Baltimore native Gina Maria DiNicolo graduated
from the U.S. Naval Academy with a degree in history and an attraction
to the unconventional. She accepted a commission in the U.S. Marine
Corps where she worked in aviation, recruiting, history, and public
affairs. As a fulltime author and historian, in addition to her two
books, DiNicolo has written scores of articles for the Military Officer
Magazine and other publications. After publishing Blood Stripe, she
sought to get her historian game on and accepted a one-year, work/study
assignment as a senior editor for the U.S. Army Center of Military
History in Washington, D.C., producing studies on military operations
in Iraq and Afghanistan. She is a dancer specializing in Argentine
Tango. For a review copy of Blood Stripe: The Susanna
Marcasi Chronicles or to arrange an interview with Gina Maria
DiNicolo contact Scott Lorenz of Westwind Communications Book
Marketing http://www.book-marketing-expert.com/ or by phone
734-667-2090.
Wella Professionals collaborated with a team of top creative artists, including Global Creative Directors, Eugene Souleiman (Styling) and Josh Wood (Color), to identify the future of hair, color and style for 2015. Encompassed within the TrendVision platform, each distinct trend celebrates unique pathways to inspire stylists. Offering hairdressers the opportunity to showcase their highest level of creativity and craftsmanship for over 11 years, TrendVision heroes the most skilled hairdressers, allowing them to compete for the chance to interpret Wella trends at International TrendVision, which will take place in Berlin later this year.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7504951-wella-2015-hair-trend-report/
Change within the PR industry continued to accelerate in 2014 as more brands recognized their own power as publishers. In response to the growing demand for compelling content, PR Newswire’s clients rose to the challenge through narrative storytelling, use of rich visuals and an intelligent mix of distribution channels to amplify their messages.
On average, over 1,000 stories cross the wires in North America each day. With time remaining in 2014, PR Newswire’s editorial teams have already made over 40,000 editorial catches year to date - providing an additional layer of editorial review for your news. Helping clients achieve their strategic communications goals is the most rewarding and fulfilling aspect of what we do at PR Newswire, and our holiday video showcases some of our staff’s 2014 highlights.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7393051-happy-holidays-from-pr-newswire-2014/
Zoës Kitchen (NYSE: ZOES), a fast casual Mediterranean-inspired restaurant group, today introduced several unique ingredients to their menu, bringing the flavors and benefits of Mediterranean eating to guests via four new menu offerings.
Innovating within the restaurant space, Zoës Kitchen is the first restaurant group to introduce the lupini bean to the United States, adding this protein-packed, mild-flavored legume to their menu across 170 restaurants in 17 states. Farro will also be incorporated in the menu, an ancient, savory, fiber-rich grain that is commonly used in place of pasta and rice in the Mediterranean. Calabrian peppers, from Calabria, Italy, will add a slightly sweet and mildly spicy flavor to several dishes. Light and crispy piadina flatbread will offer guests an alternative to traditional breads used for sandwiches in the US.
To view the multimedia release go to:
http://www.multivu.com/players/English/7753651-zoes-kitchen-new-mediterranean-dishes/
Today, Atom Factory CEO Troy Carter announced plans to host a second season of Smashd Labs from September 6 to November 18. For the inaugural class, there were over 200 applicants in two weeks, six startups in the inaugural cohort, 30 mentors, founders as young as 19 years old, and over $2M raised from investments within six months of the lab’s concluding Demo Day.
“We’re proud of the success the participating startups have had to date, and look forward to growing the Smashd Labs family by adding an additional set of startups led by talented founders with platforms and tech that can disrupt entertainment and culture,” stated Atom Factory CEO Troy Carter, who most recently served as a guest shark on the latest season of ABC’s hit prime-time show Shark Tank.
To view the multimedia release go to:
http://www.multivu.com/players/English/7817451-atom-factory-smashd-labs-startups/
As the most-visited travel destination in the United States, the Orlando tourism community was quickly up and running post-Hurricane Irma, hosting eager visitors from around the world. Due to a strong tourism infrastructure that hosts an average of 500,000 visitors a day, the region maintains a high level of preparedness for storms and historically resumes operations soon after.
Immediately after the storm, the hospitality industry began quickly clearing debris and returning the destination to normal business operations. Within a matter of days, all of the major theme parks were operational, as were both airports and Orlando’s wide range of attractions, hotels and restaurants.
To view the multimedia release go to:
https://www.multivu.com/players/English/8180451-visit-orlando-post-irma/
Today, Novo Nordisk announced new phase 3 interim data from its guardianTM2 trial for its recombinant coagulation factor VIII (rFVIII) product NovoEight® (turoctocog alfa), the first new rFVIII molecule in over a decade, which shows that it provides long-term reduction from bleeding in people with haemophilia A when used as a preventative treatment.1 The results were presented at the World Federation of Haemophilia (WFH) World Congress and support findings from other studies within the guardianTM clinical programme that found NovoEight® demonstrated good efficacy in preventing and treating bleeds without inhibitor development in previously treated patients.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/71400529-novoeight-reduction-of-bleeding-haemophilia-a
In order to succeed in today’s B2B sales world, salespeople must create buyer consensus among diverse customer stakeholders. Those who fail to do that risk falling victim to the status-quo – the minimal-risk, lowest-cost option – or worse, losing the deal altogether. The Challenger Customer: Selling to the Hidden Influencer Who Can Multiply Your Results from CEB (NYSE: CEB), a best practice insight and technology company, reveals that it isn’t just about how you engage, but who you engage within the customer organization that drives complex sales today.
“The ‘senior decision-maker’ no longer exists in B2B sales. That makes the most significant problem facing marketing and sales teams a buying problem, not a selling problem. Organizations need to shift their focus from making the sale to understanding buyer groups – and who among them really shapes decisions,” said co-author Brent Adamson, executive advisor at CEB. “Our research shows that the one thing that matters most to executives is whether or not a supplier has buy-in with the rest of the organization – NOT the supplier’s actual offering or solution.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7427252-ceb-the-challenger-customer/
2017 Renault Zoe
Renault has introduced a new Z.E. 40 battery for ZOE. At the same, ZOE owners can benefit from a range of new connected services and equipment upgrades. Order books for the new ZOE line-up are open. The new ZOEs fitted with the new Z.E. 40 battery are made at Renault's Flins plant in France and will be available for delivery before the end of 2016.
Double the range for even longer journeys
As the pioneer of all-electric mobility and Europe's number one seller of electric vehicles, Renault has stepped up its innovation programme and the deployment of its Zero Emissions strategy.
Fitted with the new Z.E. 40 battery, the Renault ZOE now delivers a record NEDC driving range of 400km, which is twice the distance delivered by the model at the time of its original launch.
The new Z.E. 40 battery has a real-world range of 300 kilometres in urban or suburban areas, for example.
The range permitted today by the ZOE is the longest of any mainstream all-electric vehicle and motorists can take advantage of this step forward now.
The ZOE is the best-selling electric vehicle in Europe and provides a real alternative to internal combustion-engine cars, since average daily commuting distances are well within the ZOE's capabilities.
The new battery removes the final psychological barrier that stands in the way of buying an electric car since ZOE users can now travel further and enjoy a wider variety of driving situations without worry about charging. This makes weekend trips a real possibility.
The Z.E. 40 battery's charging rate is similar to that of the standard battery, so 'topping up' doesn't take long at all. For example, just 30 minutes are required on average to charge the battery for an extra 80 kilometres of driving range when plugged into one of the many public charging points in operation in Europe. The ZOE continues to be equipped with the Quick Charge function to take full advantage of the maximum capacity of fast charging points located predominantly along motorway corridors.
An innovation that doubles battery capacity with no increase in size
The ZOE's new Z.E. 40 battery boasts 41kWh of useful energy, equivalent to almost double the storage capacity of the ZOE's standard battery (22kWh of useful energy).
Developed in close partnership with LG Chem, the battery uses high-energy density lithium-ion technology.
Renault and LG engineers have succeeded in increasing storage capacity without making the battery any bigger or a lot heavier. It was optimised by working on the chemistry of the cells in order to increase their energy density, rather than stacking additional battery modules, a commonly used technique.
This major new technology has been developed while ensuring the battery's reliability or safety.
The battery's large storage capacity ensures longer range for the ZOE thanks to the meticulous work that went into integrating the battery in the vehicle. The electronic management system of the battery optimises the ZOE's energy use on the move, while the new air circulation system maintains the temperature of the ZOE's battery at a constant level, making the car economical to run in very hot or very cold weather.
There is a growing body of evidence linking yogurt consumption to improved health, and additional research to identify the scientific link between yogurt and potential health benefits, is underway scientists say. International nutrition experts gathered at the First Global Summit on the Health Effects of Yogurt in Boston on April 24, 2013 to present the current state of the science on the health effects of yogurt and identify research gaps that need to be addressed within the scientific community.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61206-american-society-nutrition-health-effects-yogurt-weight-chronic-disease
